IT8620922A0 - Analoghi di amminoprostaglandine 5,6-epossi-7-ossabicicloeptano sostituite, utili nel trattamentodi trombosi. - Google Patents

Analoghi di amminoprostaglandine 5,6-epossi-7-ossabicicloeptano sostituite, utili nel trattamentodi trombosi.

Info

Publication number
IT8620922A0
IT8620922A0 IT8620922A IT2092286A IT8620922A0 IT 8620922 A0 IT8620922 A0 IT 8620922A0 IT 8620922 A IT8620922 A IT 8620922A IT 2092286 A IT2092286 A IT 2092286A IT 8620922 A0 IT8620922 A0 IT 8620922A0
Authority
IT
Italy
Prior art keywords
oxabicichloheptane
aminoprostaglandins
thrombosis
analogues
epoxy
Prior art date
Application number
IT8620922A
Other languages
English (en)
Other versions
IT1204414B (it
Inventor
Das Jagabandhu
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of IT8620922A0 publication Critical patent/IT8620922A0/it
Application granted granted Critical
Publication of IT1204414B publication Critical patent/IT1204414B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
IT20922/86A 1985-06-27 1986-06-26 Analoghi di amminoprostaglandine 5,6-epossi-7-ossabicicloeptano sostituite,utili nel trattamento di trombosi IT1204414B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/749,232 US4609671A (en) 1985-06-27 1985-06-27 5,6-epoxy-7-oxabicycloheptane substituted amino prostaglandin analogs useful in the treatment of thrombotic disease

Publications (2)

Publication Number Publication Date
IT8620922A0 true IT8620922A0 (it) 1986-06-26
IT1204414B IT1204414B (it) 1989-03-01

Family

ID=25012848

Family Applications (1)

Application Number Title Priority Date Filing Date
IT20922/86A IT1204414B (it) 1985-06-27 1986-06-26 Analoghi di amminoprostaglandine 5,6-epossi-7-ossabicicloeptano sostituite,utili nel trattamento di trombosi

Country Status (7)

Country Link
US (1) US4609671A (it)
JP (1) JPS6212779A (it)
CA (1) CA1249293A (it)
DE (1) DE3621449A1 (it)
FR (1) FR2584073B1 (it)
GB (1) GB2177091B (it)
IT (1) IT1204414B (it)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4611005A (en) * 1985-05-21 1986-09-09 E. R. Squibb & Sons, Inc. 5,6-epoxy-7-oxabicycloheptane substituted prostaglandin analogs useful in the treatment of thrombotic disease
US4734426A (en) * 1986-09-24 1988-03-29 E. R. Squibb & Sons, Inc. 5,6-epoxy-7-oxabicycloheptane substituted diamide prostaglandin analogs
JP2791380B2 (ja) * 1989-02-13 1998-08-27 株式会社フジクラ 光ファイバ母材の脱水焼結炉
DE60234057D1 (de) 2001-07-25 2009-11-26 Raptor Pharmaceutical Inc Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
EP2392258B1 (en) 2005-04-28 2014-10-08 Proteus Digital Health, Inc. Pharma-informatics system
US8795627B2 (en) 2007-03-21 2014-08-05 Raptor Pharmaceuticals Inc. Treatment of liver disorders by administration of RAP conjugates
AU2010216512B2 (en) 2009-02-20 2016-06-30 2-Bbb Medicines B.V. Glutathione-based drug delivery system
WO2010129819A2 (en) 2009-05-06 2010-11-11 Laboratory Skin Care, Inc. Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4220594A (en) * 1977-11-04 1980-09-02 E. R. Squibb & Sons, Inc. Hexa- and octahydro-4,7-epoxyisobenzofuran-1-ol and hexa- and octahydro-5,8-epoxy-1H-2-benzopyran-3-ol
US4254044A (en) * 1977-11-04 1981-03-03 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane- and 7-oxabicycloheptene compounds
US4187236A (en) * 1977-11-04 1980-02-05 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane compounds
US4143054A (en) * 1977-11-04 1979-03-06 E. R. Squibb & Sons, Inc. 7-oxabicycloheptane- and 7-oxabicycloheptene compounds
EP0045118B1 (en) * 1979-01-05 1984-04-04 National Research Development Corporation Intermediates for the synthesis of bicyclo (2,2,1) heptanes and bicyclo (2,2,1) hept-2z-enes
US4228180A (en) * 1979-11-01 1980-10-14 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane and 7-oxabicycloheptene prostaglandin analogs
ZA829068B (en) * 1980-07-01 1983-02-23 Nat Res Dev Prostaglandins
US4416896A (en) * 1982-05-17 1983-11-22 E. R. Squibb & Sons, Inc. 7-Oxabicyclopheptane substituted amino prostaglandin analogs useful in the treatment of thrombolytic disease
US4456617A (en) * 1983-01-12 1984-06-26 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane substituted amino prostaglandin analogs and their use in inhibiting platelet aggregation and bronchoconstriction

Also Published As

Publication number Publication date
FR2584073A1 (fr) 1987-01-02
GB2177091A (en) 1987-01-14
GB8615140D0 (en) 1986-07-23
FR2584073B1 (fr) 1988-08-19
DE3621449A1 (de) 1987-01-02
CA1249293A (en) 1989-01-24
IT1204414B (it) 1989-03-01
US4609671A (en) 1986-09-02
JPS6212779A (ja) 1987-01-21
GB2177091B (en) 1989-05-04

Similar Documents

Publication Publication Date Title
DK336587D0 (da) Alfa-aryl-alfa-phenylethyl-1h-1,2,4-triazol-1-propannitriler
FI870082A0 (fi) Munstycksarrangemang i tvao delar foer skummedel.
DE3670647D1 (de) Schaeumbare organopolysiloxanzusammensetzungen.
DE3689377D1 (de) Zufallsfolgengeneratoren.
FI872861A0 (fi) Kaopa foer insaettning i en kopplingstavla.
DE3769523D1 (de) Schraubenkompressor.
DE3787529D1 (de) Strahlmittelbehandlung.
NO862970D0 (no) 3-propenylcephalosporinsolvater.
FI872276A (fi) Monteringsarrangemang foer inloppsventil i centralsugsystem.
FI861561A0 (fi) Substituerad 2,3,4,9-tetrahydro-1h -karbazol-1-aettikasyra.
FI870980A0 (fi) Atomreaktor foersedd med i laengdriktningen laongstraeckt kaerl.
IT8620922A0 (it) Analoghi di amminoprostaglandine 5,6-epossi-7-ossabicicloeptano sostituite, utili nel trattamentodi trombosi.
IT8620970A0 (it) Eteri 5,6-epossi-7-ossabicicloeptano sostituiti utili nel trattamento di trombosi.
FI872277A (fi) Abonnentanslutning i en telefonanlaeggning.
FI870932A0 (fi) Bestraolningsanordning foer solenergi i medicinskt bruk.
FI872247A0 (fi) Eldosa foer montering i kabelraenna.
IT8620179A0 (it) Analoghi di tioprostaglandina 7-ossabicicloeptano sostituiti.
FI854730A0 (fi) Vattentorn 2000.
IT8519224A0 (it) Analoghi di ossaprostaglandina 7-ossabicicloeptano sostituiti.
FI861940A0 (fi) Stoedanordning foer nackstycket i en borrmaskin.
NO860872L (no) Superplastisk forming.
FI874227A0 (fi) Radiosaendare-mottagare i elektrisk transmissionsteknik.
DE3675155D1 (de) Sulfoalkylierungsverfahren.
IT8522959A0 (it) Analoghi di postacicline.
DK291687A (da) 2-phenylacetyl-1,3,5-cyklohexantrioner